Literature DB >> 1924894

Centrally administered NPY stimulated gastric acid and pepsin secretion by a vagally mediated mechanism.

M Matsuda1, M Aono, M Moriga, M Okuma.   

Abstract

We investigated the possible roles of centrally administered neuropeptide Y (NPY) on gastric secretion, serum gastrin levels and gastric mucosal blood flow in anesthetized rats. Centrally administered NPY dose-dependently stimulated gastric acid and pepsin secretion. The stimulatory effect of intracerebroventricular administration of NPY was more potent than that of intracisternal administration. Centrally administered NPY also increased gastric secretion in the central noradrenaline depleted rats. In contrast, intravenously administered NPY had no influence on gastric secretion. These stimulatory effects were abolished by vagotomy or atropine pretreatment. The serum gastrin levels did not change after central NPY injection. Although intravenously administered NPY slightly increased gastric mucosal blood flow, centrally administered NPY slightly diminished gastric mucosal blood flow. These results indicate that centrally administered NPY markedly influences gastric functions in the rat.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1924894     DOI: 10.1016/0167-0115(91)90251-b

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  11 in total

1.  Regulation of hepatic function by brain neuropeptides.

Authors:  Masashi Yoneda
Journal:  World J Gastroenterol       Date:  1998-06       Impact factor: 5.742

Review 2.  Brain-gut axis of the liver: the role of central neuropeptides.

Authors:  Masashi Yoneda; Mieko Kurosawa; Hajime Watanobe; Tadahito Shimada; Akira Terano
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

3.  Nesfatin-1 inhibits gastric acid secretion via a central vagal mechanism in rats.

Authors:  Ze-Feng Xia; Danielle M Fritze; Ji-Yao Li; Biaoxin Chai; Chao Zhang; Weizhen Zhang; Michael W Mulholland
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-06-21       Impact factor: 4.052

4.  Synergistic effects of genetic beta cell dysfunction and maternal glucose intolerance on offspring metabolic phenotype in mice.

Authors:  S M Lau; S Lin; R A Stokes; K Cheng; P A Baldock; R F Enriquez; M McLean; N W Cheung; A Sainsbury; F J Gonzalez; H Herzog; J E Gunton
Journal:  Diabetologia       Date:  2010-12-22       Impact factor: 10.122

Review 5.  Thirteenth Gaddum Memorial Lecture. Neuronal and endothelium-derived mediators in the modulation of the gastric microcirculation: integrity in the balance.

Authors:  B J Whittle
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

6.  Ghrelin action in the brain controls adipocyte metabolism.

Authors:  Claudia Theander-Carrillo; Petra Wiedmer; Philippe Cettour-Rose; Ruben Nogueiras; Diego Perez-Tilve; Paul Pfluger; Tamara R Castaneda; Patrick Muzzin; Annette Schürmann; Ildiko Szanto; Matthias H Tschöp; Françoise Rohner-Jeanrenaud
Journal:  J Clin Invest       Date:  2006-06-08       Impact factor: 14.808

7.  Centrally administered neuropeptide Y (NPY) inhibits gastric emptying and intestinal transit in the rat.

Authors:  M Matsuda; M Aono; M Moriga; M Okuma
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

8.  Central neuropeptide Y and the sigma ligand, JO 1784, reverse corticotropin-releasing factor-induced inhibition of gastric acid secretion in rats.

Authors:  M Gué; M Yoneda; H Mönnikes; J L Junien; Y Taché
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

9.  Stimulation of gastric secretion and enhanced gastric mucosal damage following central administration of pancreatic polypeptide (PP) in rats.

Authors:  T Okumura; T N Pappas; I L Taylor
Journal:  Dig Dis Sci       Date:  1994-11       Impact factor: 3.199

10.  Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats.

Authors:  M Gué; J L Junien; J R Reeve; J Rivier; D Grandt; Y Taché
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.